Discover
OKUR
OnKure Therapeutics, Inc.
4.17
6 x 4.18
5 x 4.20
bid
ask
+
0.05
1.21%
1 @ 04:00 PM
4.13 -0.04 (0.96%)
| Ytd | 43.79% | |
| 1y | 79.74% |
3.91
day range
4.21
1.91
52 week range
5.38
| Open | 4.00 | Prev Close | 4.12 | Low | 3.91 | High | 4.21 | Mkt Cap | 57.02M |
| Vol | 144.08K | Avg Vol | 300.85K | EPS | -4.33 | P/E | -0.96 | Forward P/E | -2.64 |
| Beta | 0.27 | Short Ratio | 19.81 | Inst. Own | 53.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 4.12 | 200-d Avg | 3.52 | 1yr Est | 34.75 |
| Income Statement | |||
| Operating Expenses | 15.62M | ||
| Research and Development Expense | 11.71M | ||
| Selling, General and Administrative Expense | 3.91M | ||
| Operating Income | -15.61M | ||
| Net Income | -15.16M | ||
| Net Income Common Stock | -15.16M | ||
| Net Income Common Stock (USD) | -15.16M | ||
| Consolidated Income | -15.16M | ||
| Earnings per Basic Share | -1.11 | ||
| Earnings per Basic Share (USD) | -1.11 | ||
| Earnings per Diluted Share | -1.11 | ||
| Earning Before Interest & Taxes (EBIT) | -15.16M | ||
| Earning Before Interest & Taxes (USD) | -15.16M | ||
| Weighted Average Shares | 13.67M | ||
| Weighted Average Shares Diluted | 13.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 192.11M | ||
| Cash and Equivalents (USD) | 192.11M | ||
| Current Assets | 197.48M | ||
| Property, Plant & Equipment Net | 807.00K | ||
| Total Assets | 198.69M | ||
| Debt Current | 409.00K | ||
| Total Debt | 409.00K | ||
| Current Liabilities | 14.33M | ||
| Total Liabilities | 14.34M | ||
| Accumulated Retained Earnings (Deficit) | -229.40M | ||
| Shareholders Equity | 184.35M | ||
| Shareholders Equity (USD) | 184.35M | ||
| Assets Non-Current | 1.21M | ||
| Total Debt (USD) | 409.00K | ||
| Liabilities Non-Current | 12.00K | ||
| Trade and Non-Trade Payables | 11.02M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 203.00K | ||
| Net Cash Flow from Financing | 146.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 133.06M | ||
| Capital Expenditure | -5.00K | ||
| Net Cash Flow from Investing | -5.00K | ||
| Net Cash Flow from Operations | -12.94M | ||
| Share Based Compensation | 2.78M | ||